Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2021

Mar 15, 2021

5262_dirs_2021-03-15_6d0310cb-ea93-4a7f-ac54-330b41d72f89.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 3225S

GlaxoSmithKline PLC

15 March 2021

GlaxoSmithKline plc (the 'Company')

Transaction notification

1. Details of PDMR/person closely associated with them ('PCA')
a) Name Dr H Barron
b) Position/status Chief Scientific Officer and President, R&D
c) Initial notification/

amendment
Initial notification
2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name GlaxoSmithKline plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a) Description of the financial instrument American Depositary Shares ('ADSs')

ISIN: US37733W1053
b) Nature of the transaction Acquisition of notional ADSs within Dr Barron's GSK Executive Supplemental Savings Plan account
c) Price(s) and volume(s) Price(s) Volume(s)
$35.5400 23,206.796
d) Aggregated information N/A (single transaction)
Aggregated volume Price
e) Date of the transaction 2021-03-12
f) Place of the transaction New York Stock Exchange (XNYS)
1. Details of PDMR/person closely associated with them ('PCA')
a) Name Dr H Barron
b) Position/status Chief Scientific Officer and President, R&D
c) Initial notification/

amendment
Initial notification
2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name GlaxoSmithKline plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a) Description of the financial instrument American Depositary Shares ('ADSs')

ISIN: US37733W1053
b) Nature of the transaction Acquisition of ADSs within Dr Barron's GSK 401(k) Plan account
c) Price(s) and volume(s) Price(s) Volume(s)
$35.5400 565
d) Aggregated information N/A (single transaction)
Aggregated volume Price
e) Date of the transaction 2021-03-12
f) Place of the transaction New York Stock Exchange (XNYS)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDELFFFXLLBBX